Sfoglia per AUTORE
DI FEDERICO A
Collezione AOU San Luigi di Orbassano
Items : 3
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors. in JAMA network open / JAMA Netw Open. 2025 Jan 2;8(1):e2456058. doi: 10.1001/jamanetworkopen.2024.56058.
2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Di Federico A; Fanti S; Vincenzi B; Dimino A; Gasperoni S; Incorvaia L; Badalamenti G; Merlini A; D'Ambrosio L; Grignani G; Grimaudo MS; Bertuzzi AF; De Luca I; Fumagalli ER; Marchetti A; Nigro MC; Campana D; Pantaleo MA; Nannini M;
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1?50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. in Journal for immunotherapy of cancer / J Immunother Cancer. 2025 Feb 4;13(2):e010674. doi: 10.1136/jitc-2024-010674.
2025
AOU San Luigi di Orbassano
AOU Novara
AOU San Luigi di Orbassano
AOU Novara
Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...
Letter Re: Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Dec;213:115085. doi: 10.1016/j.ejca.2024.115085. Epub 2024 Oct 28.
2024
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Sini C; Di Federico A; Bironzo P; De Giglio A; Gelsomino F;